However, TFDP1, a potential global modulator of chromatin accessibility by controlling histone transcription (74), shows contrasting differential binding activities when comparing PiD with AD (Fig. 5A), suggesting potential discrepancy in genome-wide TFDP1 TF binding activity between diseases. Here, MTA2 is linked to Alzheimer disease.